CSIMarket Company Name, Ticker, Customers, else..
 

Regenerx Biopharmaceuticals inc   (NONE: RGRX)

Regenerx Biopharmaceuticals Inc 's

Competitiveness



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

 

RGRX Sales vs. its Competitors Q1 2023


Comparing the current results to its competitors, Regenerx Biopharmaceuticals Inc reported Revenue decrease in the 1 quarter 2023 year on year by -0.01 %, despite the revenue increase by the most of its competitors of 36.65 %, recorded in the same quarter.

• List of RGRX Competitors





Revenue Growth Comparisons




Net Income Comparison

Regenerx Biopharmaceuticals inc , slower than the average decrease reported by the company's competitors of -30.82 %. recorded a net loss and most of the company's competitors saw a decline in earnings by -30.82 %

<<  RGRX Stock Performance Comparisons





  

Overall company Market Share Q1 2023
Overall company, revenue fell by -0.01 % and company lost market share, to approximately 0 %.




<<  More on RGRX Market Share.
 
*Market share is calculated based on total revenue.





Publicly Traded Peers of Regenerx Biopharmaceuticals inc




Johnson and Johnson
Share Performance



+52.34%
One Year
Johnson and Johnson
Profile

Johnson & Johnson operates as a multinational healthcare company with a diversified business model that spans pharmaceuticals, medical devices, and consumer health products. By focusing on innovation and strategic acquisitions, the company aims to improve global health and well-being.

More about Johnson and Johnson's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 656,801.717 mill. $ 97,929.000 mill. $ 21,037.000 mill.


Novabridge Biosciences
Share Performance



-64.17%
This Year
Novabridge Biosciences
Profile

The company develops drug candidates and conducts related research and development activities in China.

More about Novabridge Biosciences's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 146.520 mill. $ - mill. $ -88.340 mill.


Neubase Therapeutics inc
Share Performance



+83.50%
One Year
Neubase Therapeutics inc
Profile

Neubase Therapeutics Inc is a biotechnology company focused on developing and commercializing small molecule therapies for genetic diseases. They aim to leverage their proprietary modular antisense oligonucleotide platform to create therapeutics that can specifically target and treat multiple genetic diseases.

More about Neubase Therapeutics inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 1.042 mill. $ - mill. $ -13.730 mill.


Nucana Plc
Share Performance



-10.88%
30 Days
Nucana Plc
Profile

Nucana Plc is a pharmaceutical company that focuses on developing novel treatments for cancer and other diseases.

More about Nucana Plc's Market Share

Market Cap. Revenues TTM Net Income TTM
$ - mill. $ - mill. $ -70.922 mill.


Nurix Therapeutics Inc
Share Performance



+174.48%
One Year
Nurix Therapeutics Inc
Profile

Nurix Therapeutics Inc's business model involves developing targeted protein degradation therapies to treat diseases by modulating the body's cellular protein levels.

More about Nurix Therapeutics Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 2,652.696 mill. $ 36.766 mill. $ -341.351 mill.

96 more competitors available

Sign in to see all competitors

Sign In Create Free Account

Sources: Regenerx Biopharmaceuticals inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Regenerx Biopharmaceuticals inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.